ACE and COVID-19: Furthermore, inhibition of ACE caused an increase in bradykinin levels and bronchoconstriction, which induced cough, a common symptom seen in COVID-19 patients (Al-Shamlan and El-Hashim, 2019; Mahmoudpour et al., 2013).